6533b7d8fe1ef96bd126a4ad

RESEARCH PRODUCT

A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease

Grazia PennisiRosaria Maria PipitoneDaniela CabibiMarco EneaManuel Romero‐gomezMauro ViganòElisabetta BugianesiVincent Wai‐sun WongAnna Ludovica FracanzaniGiada SebastianiAnnalisa BerzigottiFrancesca Di SalvoAntonino Giulio GiannoneClaudia La MantiaGiulia LupoRossana PorcasiFederica VernuccioRossella ZitoVito Di MarcoCalogero CammàAntonio CraxìVictor De LedinghenStefania GrimaudoSalvatore Petta

subject

Liver CirrhosisCholestasisHepatologyBiopsyNASHNAFLD Cholestasis Cirrhosis Fibrosis Hepatocellular carcinoma Liver-related events Liver decompensation610 Medicine & healthMiddle AgedFibrosisLiverCirrhosisNon-alcoholic Fatty Liver DiseaseNAFLDHumans610 Medicine & health

description

NAFLD patients usually have an increase in AST/ALT levels, but cholestasis can also be observed. We aimed to assess in subjects with NAFLD the impact of the (cholestatic) C pattern on the likelihood of developing major liver-related outcomes (MALO).

yearjournalcountryeditionlanguage
2022-05-01
10.1111/liv.15232https://api.elsevier.com/content/abstract/scopus_id/85126031397